LivaNova Executive and Leadership Team

June, 2026

Leadership Overview

LivaNova has 5 executives leading key functions including technology, information systems, and regional operations.

Driven by innovation in medical technology, LivaNova is dedicated to developing therapeutic solutions that improve patient outcomes and enhance quality of life across its global operations.

Leadership Roles at LivaNova

  • President, North America - Paul Buckman
  • President (China) - Christina Lu
  • President - Catherine Sheng
  • Chief Information Officer - Sai Yedavelli
  • Chief Technology Officer - Dan Suarasan
  • Paul Buckman - President, North America

    Paul Buckman, the President, North America at LivaNova, directs all commercial and operational activities within the North American region. Buckman oversees the strategic deployment of LivaNova's therapeutic solutions, including products for cardiopulmonary support and neuromodulation, across the United States and Canada. This leadership role involves driving market penetration, managing sales channels, and ensuring customer satisfaction for hospitals and healthcare providers. By cultivating strong relationships with key stakeholders, Paul Buckman ensures LivaNova's advanced medical devices reach patients who need them most. The President, North America's efforts are vital for expanding the company's footprint and reinforcing its commitment to improving patient outcomes across the continent.
    Paul Buckman

    Christina Lu - President (China)

    Christina Lu, the President (China) at LivaNova, leads the company's strategic initiatives and market development within the critical Chinese region. Lu is responsible for expanding LivaNova's presence and ensuring the successful adoption of its innovative medical devices, including those for cardiopulmonary and neuromodulation applications. This executive function involves navigating the unique regulatory landscape and market dynamics of China to drive revenue growth and patient access. By fostering local partnerships and adapting global strategies to regional needs, Christina Lu plays a pivotal role in LivaNova's international expansion. The President (China)'s leadership is essential for capitalizing on the significant opportunities within this key global market.
    Christina Lu

    Catherine Sheng - President

    Catherine Sheng, the President at LivaNova, drives the company's strategic growth and operational excellence across key global markets. Sheng oversees the integration of LivaNova's diverse product portfolio, encompassing cardiopulmonary, neuromodulation, and advanced circulatory support solutions. This executive responsibility involves aligning business objectives with market demands and ensuring the efficient delivery of life-changing medical technologies. By championing innovation and fostering cross-functional collaboration, Catherine Sheng enhances LivaNova's competitive position and commitment to patient well-being. The President's focus on strategic execution is fundamental to achieving the company's mission of improving global health outcomes.
    Catherine Sheng

    Sai Yedavelli - Chief Information Officer

    Sai Yedavelli, the Chief Information Officer at LivaNova, directs the company's global information technology strategy and infrastructure. Overseeing all aspects of digital operations, Yedavelli ensures the secure and efficient management of data critical to LivaNova's medical device development and manufacturing processes. This leadership role involves architecting scalable IT solutions that support the Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. By optimizing enterprise systems and cybersecurity measures, Sai Yedavelli directly enhances operational resilience and supports the company's mission to deliver life-saving therapeutic solutions worldwide. The Chief Information Officer's focus remains on leveraging technology to drive innovation and maintain a competitive edge in the medical device industry.
    Sai Yedavelli

    Dan Suarasan - Chief Technology Officer

    Dan Suarasan, the Chief Technology Officer at LivaNova, spearheads the company's technological vision and innovation pipeline. Suarasan guides the research and development efforts across all business segments, focusing on advancing the capabilities of LivaNova's therapeutic solutions. This executive position involves translating cutting-edge scientific discoveries into tangible medical devices, particularly for the Cardiopulmonary and Neuromodulation divisions. By fostering a culture of technological excellence, Dan Suarasan ensures LivaNova remains at the forefront of medical device engineering. The Chief Technology Officer's strategic direction is crucial for developing next-generation products that address unmet clinical needs and improve patient care globally.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding LivaNova Top Executives and Leadership Team

    Who leads LivaNova?
    LivaNova is led by Paul Buckman (President, North America), along with executives such as Christina Lu (President (China)) and Catherine Sheng (President).
    Who is part of LivaNova’s executive team?
    The executive team of LivaNova includes leaders such as Paul Buckman (President, North America), Christina Lu (President (China)), Catherine Sheng (President) and other senior executives.
    How many executives does LivaNova have?
    LivaNova has 5 executives leading key business areas.
    What roles are included in LivaNova’s leadership team?
    The leadership team of LivaNova includes roles such as President, North America, President (China), President, Chief Information Officer, Chief Technology Officer.